Frazier Life Sciences

SEATTLE, WA

Frazier Life Sciences has raised over $1.6B across 5 funds since 2008. Based in San Francisco and Seattle, Frazier is a healthcare-focused private equity and venture firm investing across clinical-stage biopharmaceuticals, medical devices, and healthcare services, with a focus on oncology, rare disease, and immunology.

Funds Raised

Total $ Raised

$1.6B

Est. Dry Powder

4yr linear

Last Fund

2022-03-15

Estimated dry powder over time

Linear 4-year deployment model per fund

All funds (5)

Fund	Raise Date	Filed	Raised	Est. Dry Powder	SEC
Frazier Life Sciences X, L.P.	Currently Raising	2019-12-17	—	Deployed	↗
Frazier Life Sciences XII, L.P.	Currently Raising	2025-03-17	—	Deployed	↗
Frazier Life Sciences XI, L.P.	2022-03-15	2022-03-18	$960M	Deployed	↗
Frazier Life Sciences IX, L.P.	2017-10-31	2017-11-01	$419M	Deployed	↗
Frazier Life Sciences VIII, L.P.	2015-10-15	2015-10-29	$262M	Deployed	↗